PortfoliosLab logoPortfoliosLab logo
AMRX vs. STRT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AMRX vs. STRT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amneal Pharmaceuticals, Inc. (AMRX) and Strattec Security Corporation (STRT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AMRX achieves a 27.86% return, which is significantly higher than STRT's 4.08% return. Over the past 10 years, AMRX has underperformed STRT with an annualized return of -5.79%, while STRT has yielded a comparatively higher 7.51% annualized return.


AMRX

1D
-0.62%
1M
29.71%
YTD
27.86%
6M
25.66%
1Y
106.01%
3Y*
77.51%
5Y*
25.09%
10Y*
-5.79%

STRT

1D
-0.71%
1M
9.40%
YTD
4.08%
6M
-1.74%
1Y
38.38%
3Y*
65.45%
5Y*
11.61%
10Y*
7.51%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AMRX vs. STRT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AMRX
Amneal Pharmaceuticals, Inc.
27.86%59.09%30.48%205.03%-58.46%4.81%-5.19%-64.38%-18.74%25.66%
STRT
Strattec Security Corporation
4.08%84.81%62.59%23.31%-44.49%-25.00%123.78%-21.04%-32.75%9.81%

Correlation

The correlation between AMRX and STRT is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.33

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.13

Correlation (10Y)
Calculated over the trailing 10-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Jan 15, 2009

0.10

Over the past year, AMRX and STRT have become more correlated (0.33) than their long-term average of 0.10, meaning their price movements have been converging.

Fundamentals

Market Cap

AMRX:

$5.30B

STRT:

$327.54M

EPS

AMRX:

$0.38

STRT:

$6.06

PE Ratio

AMRX:

42.82

STRT:

13.08

PEG Ratio

AMRX:

1.49

STRT:

0.36

PS Ratio

AMRX:

1.72

STRT:

0.56

PB Ratio

AMRX:

6.90

STRT:

1.36

Total Revenue (TTM)

AMRX:

$3.05B

STRT:

$579.58M

Gross Profit (TTM)

AMRX:

$1.18B

STRT:

$97.12M

EBITDA (TTM)

AMRX:

$626.02M

STRT:

$36.69M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AMRX vs. STRT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMRX
AMRX Risk / Return Rank: 9393
Overall Rank
AMRX Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
AMRX Sortino Ratio Rank: 9595
Sortino Ratio Rank
AMRX Omega Ratio Rank: 9494
Omega Ratio Rank
AMRX Calmar Ratio Rank: 9191
Calmar Ratio Rank
AMRX Martin Ratio Rank: 9090
Martin Ratio Rank

STRT
STRT Risk / Return Rank: 6565
Overall Rank
STRT Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
STRT Sortino Ratio Rank: 6262
Sortino Ratio Rank
STRT Omega Ratio Rank: 6161
Omega Ratio Rank
STRT Calmar Ratio Rank: 6666
Calmar Ratio Rank
STRT Martin Ratio Rank: 6767
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AMRX vs. STRT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amneal Pharmaceuticals, Inc. (AMRX) and Strattec Security Corporation (STRT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AMRXSTRTDifference
Sharpe ratioReturn per unit of total volatility

+2.53

Sortino ratioReturn per unit of downside risk

+2.70

Omega ratioGain probability vs. loss probability

1.50

1.16

+0.34

Calmar ratioReturn relative to maximum drawdown

4.79

1.23

+3.56

Martin ratioReturn relative to average drawdown

11.85

2.79

+9.06

AMRX vs. STRT - Sharpe Ratio Comparison

The current AMRX Sharpe Ratio is 3.32, which is higher than the STRT Sharpe Ratio of 0.79. The chart below compares the historical Sharpe Ratios of AMRX and STRT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AMRX vs. STRT - Drawdown Comparison

The maximum AMRX drawdown since its inception was -97.52%, which is greater than STRT's maximum drawdown of -89.98%. Use the drawdown chart below to compare losses from any high point for AMRX and STRT.


Loading charts...

Drawdown Indicators


AMRXSTRTDifference

Max Drawdown

Largest peak-to-trough decline

-97.52%

-89.98%

-7.54%

Max Drawdown (1Y)

Largest decline over 1 year

-22.25%

-31.31%

+9.06%

Max Drawdown (3Y)

Largest decline over 3 years

-26.80%

-36.82%

+10.02%

Max Drawdown (5Y)

Largest decline over 5 years

-78.29%

-62.13%

-16.16%

Max Drawdown (10Y)

Largest decline over 10 years

-95.98%

-74.35%

-21.63%

Current Drawdown

Current decline from peak

-68.60%

-19.98%

-48.62%

Average Drawdown

Average peak-to-trough decline

-54.34%

-40.61%

-13.73%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.98%

13.78%

-4.80%

Volatility

AMRX vs. STRT - Volatility Comparison

Amneal Pharmaceuticals, Inc. (AMRX) has a higher volatility of 11.49% compared to Strattec Security Corporation (STRT) at 8.45%. This indicates that AMRX's price experiences larger fluctuations and is considered to be riskier than STRT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AMRXSTRTDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.49%

8.45%

+3.04%

Volatility (6M)

Calculated over the trailing 6-month period

24.31%

34.34%

-10.03%

Volatility (1Y)

Calculated over the trailing 1-year period

32.20%

49.19%

-16.99%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

50.98%

49.16%

+1.82%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

65.26%

53.53%

+11.73%

Dividends

AMRX vs. STRT - Dividend Comparison

Neither AMRX nor STRT has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
AMRX
Amneal Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
STRT
Strattec Security Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.28%2.52%1.94%1.29%1.34%0.89%

Financials

AMRX vs. STRT - Financials Comparison

This section allows you to compare key financial metrics between Amneal Pharmaceuticals, Inc. and Strattec Security Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M400.00M600.00M800.00M20222023202420252026
722.52M
137.63M
(AMRX) Total Revenue
(STRT) Total Revenue
Values in USD except per share items

AMRX vs. STRT - Profitability Comparison

The chart below illustrates the profitability comparison between Amneal Pharmaceuticals, Inc. and Strattec Security Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

10.0%20.0%30.0%40.0%20222023202420252026
44.3%
16.5%
Portfolio components
AMRX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Amneal Pharmaceuticals, Inc. reported a gross profit of 320.11M and revenue of 722.52M. Therefore, the gross margin over that period was 44.3%.

STRT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Strattec Security Corporation reported a gross profit of 22.66M and revenue of 137.63M. Therefore, the gross margin over that period was 16.5%.

AMRX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Amneal Pharmaceuticals, Inc. reported an operating income of 133.54M and revenue of 722.52M, resulting in an operating margin of 18.5%.

STRT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Strattec Security Corporation reported an operating income of 5.05M and revenue of 137.63M, resulting in an operating margin of 3.7%.

AMRX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Amneal Pharmaceuticals, Inc. reported a net income of 62.50M and revenue of 722.52M, resulting in a net margin of 8.7%.

STRT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Strattec Security Corporation reported a net income of 3.24M and revenue of 137.63M, resulting in a net margin of 2.4%.


Frequently Asked Questions


AMRX and STRT have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AMRX has higher volatility (11.49%) compared to STRT (8.45%). In terms of maximum drawdown, AMRX dropped -97.52% vs STRT's -89.98%.

AMRX currently has the higher Sharpe Ratio (3.32 vs 0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AMRX and STRT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer